RPG Life Sciences Ltd.

2,342

7.7 (0.3%)

As on January 9, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap3,873 Cr
P/E Ratio21.14
Dividend Yield0.13 %
Trendline Performance

Unlock Stock of the Month

T&C*

Company Information


Market Insights
Open2,335
High2,350.9
NSE SymbolRPGLIFE
Close2,342
Low2,275.9
BSE Symbol532983
Previous Years High/Low
1 Year High2,725
3 Year High2,974.95
5 Year High2,974.95
1 Year Low1,835
3 Year Low645.5
5 Year Low359.75

Technicals


IndicatorsValueSignal
5-DMA2,328.52Bullish
10-DMA2,320.01Bullish
20-DMA2,333.13Bullish
50-DMA2,314.65Bullish
100-DMA2,328.56Bullish
200-DMA2,308.26Bullish

Historical Performance


1 Year
6%
3 Years
177.8%
5 Years
528%
10 Years
686.7%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:22.9
5 Years:44.5
3 Years:38.9
TTM:10.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 21.14, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 38.9%, indicating sustained price appreciation.
  • The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1733 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹6534 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 1168604.4
No. of Shares: 499 (Approx)
Performance:16.9%
P/L: ₹168604.4
NIFTY Performance: 9.6%
1 day Top Gainers
SymbolChange%
NATIONALUM348.05(4%)
HINDZINC606.45(3%)
OIL420.05(3%)
COFORGE1681.6(2%)
IPCALAB1575(2%)
1 Day Top Losers
SymbolChange%
ELECON423.55(-16%)
IEX138.36(-8%)
MANAPPURAM285.85(-8%)
TARIL274.3(-6%)
TEJASNET417.15(-6%)
GODREJPROP1991.5(-5%)
RADICO2945.8(-4%)
ADANIGREEN946.1(-4%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

55.5%

38.68

1 Month Performance

Panacea Biotec Ltd.

20.4%

406.2

1 Month Performance

Lasa Supergenerics Ltd.

18.3%

10.92

1 Month Performance

Dishman Carbogen Amcis Ltd.

15.3%

257.98

1 Month Performance

Kopran Ltd.

12.5%

149.16

1 Month Performance

Amanta Healthcare Ltd.

9.8%

108.81

1 Month Performance

NGL Fine-Chem Ltd.

9.7%

1419.9

1 Month Performance

Emcure Pharmaceuticals Ltd.

8.8%

1540.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month